STOCK TITAN

PreOmics Introduces a Novel BeatBox™ FFPE Workflow for Accelerated, In-depth Tissue Proteomics

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

At the AACR Annual Meeting 2023, PreOmics launched a new BeatBox-based FFPE workflow aimed at enhancing tissue proteomics applications. This workflow allows high-throughput processing of up to 96 FFPE samples simultaneously, streamlining protocol by eliminating the need for xylene-based deparaffinization. The BeatBox system ensures fast processing, typically within 10 minutes, with a demonstrated increase in proteomic depth of 14% to 43% compared to traditional methods. Bruker Corporation will co-commercialize this innovative workflow alongside its timsTOF Pro mass spectrometer. With significant time savings and improved reproducibility, this development is poised to facilitate large-scale biobank projects and enhance research efficiency in pathology.

Positive
  • Launch of BeatBox-based FFPE workflow simplifies and accelerates tissue sample processing.
  • Allows processing of up to 96 samples in parallel, enhancing throughput and efficiency.
  • Demonstrated increase in proteomic depth by 14% to 43%, improving research capabilities.
  • Partnership with Bruker for commercializing workflow to leverage market presence.
Negative
  • None.
  • Introduction of a FFPE workflow extends the tissue proteomics applications of PreOmics’ unique BeatBox™ technology
  • Launch of novel FFPE workflow enables high-throughput, robust and fast processing of tissue samples
  • Bruker and PreOmics to co-commercialize BeatBox workflows

ORLANDO, Fla.--(BUSINESS WIRE)-- At the AACR Annual Meeting 2023, PreOmics GmbH announced the launch of a BeatBox-based FFPE workflow, which simplifies, speeds up and standardizes FFPE sample preparation for deep, unbiased tissue proteomics by subsequent protein digestion and nanoLC-MS/MS analysis. The novel BeatBox workflow eliminates the need for xylene-based deparaffinization and enables fast and robust processing of up to 96 samples in parallel for discovery research, as well as for reproducible larger cohort translational and preclinical research and validation.

BeatBox is a dedicated system for convenient, semi-automated sample homogenization of many tissue types and cells (Photo: Business Wire)

BeatBox is a dedicated system for convenient, semi-automated sample homogenization of many tissue types and cells (Photo: Business Wire)

The BeatBox™ tissue homogenizer and cell lyser is a compact, affordable and stand-alone benchtop system for convenient, semi-automated sample homogenization of various tissue types and cells. With flexible input amounts from 1-50 mg, it consistently delivers reproducible results for LC-MS-based proteomics with scalable throughput from 1-96 samples. Already successful for fresh tissue and cell-line proteomics, with the novel FFPE protocol the BeatBox can now efficiently process FFPE samples for downstream tissue proteomics. Compared to sonication devices, the BeatBox requires no complex handling or additional water conditioning. FFPE or fresh frozen tissue homogenization takes just 10 minutes with push-button operation.

In a benchmark study, FFPE as well as fresh frozen mouse cardiac muscle, kidney, and liver tissue (provided by the Research Institute of Molecular Pathology in Vienna and the Histology Facility at Vienna BioCenter Core Facilities) was processed using the novel BeatBox FFPE workflow, as well as with a sonication approach. Peptides were analyzed on a timsTOF-HT mass spectrometer (Bruker Daltonics) in DIA-PASEF mode using a 30-minute nLC gradient. The BeatBox-based FFPE workflow was shown to increase the proteomic depth for FFPE, as well as for fresh frozen tissue on average by 14% to 43%, depending on tissue type. Typical Coefficients of Variation (CV) within replicates were below 10%, emphasizing the high repeatability of the homogenization process with the compact BeatBox instrument. Furthermore, the novel approach saves up to 4 hours of time in comparison to the sonication workflow, enabling parallelized high-throughput processing of 96 samples within one working day.

Dr. Michael Wierer, Director of the Proteomics Research Infrastructure at the University of Copenhagen, states: “We routinely analyze a large number of tissue samples at once, and to improve our efficiency, we have successfully adapted the BeatBox technology for tissue homogenization. Our latest discovery is that the BeatBox technology can efficiently homogenize paraffin-embedded tissue scrolls. This breakthrough now allows us to process large cohorts of FFPE tissue quickly, reproducibly, and with greater precision, opening up the possibility of large-scale biobank projects. By leveraging this technology, we are excited to uncover novel deep proteomics insights in the field of pathology research.”

Dr. Marcello Stein, Chief Marketing Officer of PreOmics, commented: “With our novel BeatBox-based FFPE workflow, researchers finally can simplify, speed-up and standardize FFPE sample preparation without the need of xylene-based deparaffinization to fully exploit its potential for unbiased, deep proteomics. We believe this is a leap forward for the preparation and subsequent proteomic analysis of large sample cohorts.”

Bruker Corporation (Nasdaq: BRKR) and PreOmics have a commercial agreement, enabling Bruker to offer the BeatBox-based tissue workflows for sale with Bruker's timsTOF Pro mass spectrometer.

Have a look yourself: PreOmics representatives will be at the AACR Bruker booth #1818 to showcase the BeatBox and FFPE application note. The application note can be accessed at https://www.preomics.com/applications/ffpe.

About PreOmics GmbH

PreOmics empowers our clients in life sciences to establish biological knowledge through efficient, reliable solutions and workflows that set the standard for protein analysis. Our team spirit, energy, and commitment empower us to be both creative and quality focused – A trusted partner with deeply rooted scientific experience. We envisage a future with revolutionary proteomic discovery processes open for everyone. Tools that reveal hidden causes of diseases, ensure sustainable nutrition, and provide diagnoses that enhance lives and society.

Website: www.preomics.com
Address: Am Klopferspitz 19 | 82152 Planegg/Martinsried | Germany

Dr. Garwin Pichler

Founder & Managing Director

PreOmics GmbH

Email: info@preomics.com

Source: Bruker Corporation

FAQ

What is the new FFPE workflow launched by Bruker?

The new FFPE workflow is a BeatBox-based system designed to simplify and speed up sample preparation for tissue proteomics.

How does the BeatBox workflow improve proteomics research?

It enables high-throughput processing of up to 96 samples simultaneously and increases proteomic depth by 14% to 43%.

When was the BeatBox FFPE workflow announced?

The BeatBox FFPE workflow was announced at the AACR Annual Meeting 2023.

What is Bruker's role in the BeatBox FFPE workflow?

Bruker is co-commercializing the BeatBox workflows and will offer them for sale with its timsTOF Pro mass spectrometer.

Bruker Corporation

NASDAQ:BRKR

BRKR Rankings

BRKR Latest News

BRKR Stock Data

8.60B
103.19M
31.92%
79.77%
1.99%
Medical Devices
Laboratory Analytical Instruments
Link
United States of America
BILLERICA